In December 2007, US drug regulators banned using Minirin nasal sprays for treating bedwetting, but said that Minirin pills are still a safe bedwetting treatment for otherwise healthy patients. The regulators reviewed the drug after two patients using Minirin nasal sprays died from hyponatremia, an imbalance of sodium levels in the body.
Indications: diabetes insipidus, renal function tests, haemorrhagic disorders
Indications: diabetes insipidus, nocturnal enuresis, polyuria, polydipsia, haemorrhagic disorders
Cranial diabetes insipidus,Primary nocturnal enuresis,Type I Von Willebrand’s disease,Testing of fibrinolytic response,Diagnosis of diabetes insipidus,Renal function testing, Nocturia associated with multiple sclerosis.
|Active ingredients: Desmopressin|